Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis Read more about Evoke Successfully Completes Phase 3 Clinical Trial Enrollment of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis
Evoke Pharma Reports Fourth Quarter and Year End 2015 Results Read more about Evoke Pharma Reports Fourth Quarter and Year End 2015 Results
Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Year End 2015 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter and Year End 2015 Financial Results
Evoke Accelerates New Drug Application Process by Engaging Regulatory Experts Read more about Evoke Accelerates New Drug Application Process by Engaging Regulatory Experts
Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility Read more about Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility
Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016 Read more about Evoke Pharma to Present Results From Successful Thorough ECG (TQT) Study of EVK-001 at Digestive Disease Week 2016
Evoke Pharma Reports Third Quarter 2015 Results Read more about Evoke Pharma Reports Third Quarter 2015 Results
Evoke to Participate in the Brean Capital 2015 Life Sciences Summit Read more about Evoke to Participate in the Brean Capital 2015 Life Sciences Summit
Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2015 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2015 Financial Results
Evoke Pharma Strengthens Financial Position Read more about Evoke Pharma Strengthens Financial Position